Vanguard Group Inc Tonix Pharmaceuticals Holding Corp. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.46 - $1.3 $668,279 - $1.89 Million
1,452,782 Added 149.0%
2,427,778 $1.43 Million
Q4 2022

Feb 10, 2023
BUY
$0.29 - $0.57 $33,808 - $66,450
116,580 Added 13.58%
974,996 $380,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $1.9 $66,905 - $239,848
126,236 Added 17.24%
858,416 $459,000
Q2 2022

Aug 12, 2022
BUY
$1.58 - $7.36 $1.16 Million - $5.39 Million
732,180 New
732,180 $1.16 Million

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email